SUMMIT RISE Study of Acute Ischemic Stroke Patients
Recruiting
Phase 4
Interventional Study
Acute Ischemic Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 500 (estimated)
- Sponsor
- Route 92 Medical, Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Acute ischemic stroke patient initially treated (first pass) with a Route 92 Medical Reperfusion System
* Informed consent completed and documented within 72 hours following thrombectomy procedure
* Endovascular treatment initiated (defined as time of groin puncture) within 8 …
Contacts